FSB Premier Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
FSB Premier Wealth Management's PFE Position: Q1 2026 in Review
FSB Premier Wealth Management reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $13.8K and leaving 10,751 shares worth $302K. The position accounts for 0.09% of the portfolio, ranked #193.
FSB Premier Wealth Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $490K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- FSB Premier Wealth Management held 10,751 shares of Pfizer worth $302K as of Q1 2026.
- FSB Premier Wealth Management sold 518 Pfizer shares in Q1 2026, an estimated $13.8K.
- Pfizer made up 0.09% of FSB Premier Wealth Management's portfolio in Q1 2026, its #193 holding.
- FSB Premier Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- FSB Premier Wealth Management's Pfizer position peaked at $490K in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.